Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analyses
J Comp Eff Res
.
2012 Mar;1(2):109-11.
doi: 10.2217/cer.12.12.
Authors
Jeremy A Rassen
1
,
Sebastian Schneeweiss
Affiliation
1
Division of Pharmacoepidemiology & Pharmacoeconomics, Department of Medicine, Brigham & Women's Hospital & Harvard Medical School, Boston, MA, USA.
PMID:
24237367
DOI:
10.2217/cer.12.12
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
MeSH terms
Comparative Effectiveness Research*
Humans
Marketing
Pharmaceutical Preparations*
Research Design
Substances
Pharmaceutical Preparations
Grants and funding
K01-HS018088/HS/AHRQ HHS/United States